Detectable Changes in The Blood Transcriptome Are Present after Two Weeks of Antituberculosis Therapy

Chloe I. Bloom, Christine M. Graham, Matthew P R Berry, Katalin A. Wilkinson, Tolu Oni, Fotini Rozakeas, Zhaohui Xu, Jose Rossello-Urgell, Damien J. Chaussabel, Jacques Banchereau, Virginia Pascual, Marc Lipman, Robert J. Wilkinson, Anne O'Garra

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

Rationale: Globally there are approximately 9 million new active tuberculosis cases and 1.4 million deaths annually<bold>.</bold> Effective antituberculosis treatment monitoring is difficult as there are no existing biomarkers of poor adherence or inadequate treatment earlier than 2 months after treatment initiation. Inadequate treatment leads to worsening disease, disease transmission and drug resistance. Objectives: To determine if blood transcriptional signatures change in response to antituberculosis treatment and could act as early biomarkers of a successful response. Methods: Blood transcriptional profiles of untreated active tuberculosis patients in South Africa were analysed before, during (2 weeks and 2 months), at the end of (6 months) and after (12 months) antituberculosis treatment, and compared to individuals with latent tuberculosis. An active-tuberculosis transcriptional signature and a specific treatment-response transcriptional signature were derived. The specific treatment response transcriptional signature was tested in two independent cohorts. Two quantitative scoring algorithms were applied to measure the changes in the transcriptional response. The most significantly represented pathways were determined using Ingenuity Pathway Analysis. Results: An active tuberculosis 664-transcript signature and a treatment specific 320-transcript signature significantly diminished after 2 weeks of treatment in all cohorts, and continued to diminish until 6 months. The transcriptional response to treatment could be individually measured in each patient. Conclusions: Significant changes in the transcriptional signatures measured by blood tests were readily detectable just 2 weeks after treatment initiation. These findings suggest that blood transcriptional signatures could be used as early surrogate biomarkers of successful treatment response.

Original languageEnglish
Article numbere46191
JournalPLoS One
Volume7
Issue number10
DOIs
Publication statusPublished - 2 Oct 2012
Externally publishedYes

Fingerprint

Transcriptome
tuberculosis
transcriptome
Biomarkers
Blood
therapeutics
blood
biomarkers
Therapeutics
Tuberculosis
hematologic tests
drug resistance
disease transmission
South Africa
Monitoring
death
Pharmaceutical Preparations
monitoring
Latent Tuberculosis
Disease Resistance

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Bloom, C. I., Graham, C. M., Berry, M. P. R., Wilkinson, K. A., Oni, T., Rozakeas, F., ... O'Garra, A. (2012). Detectable Changes in The Blood Transcriptome Are Present after Two Weeks of Antituberculosis Therapy. PLoS One, 7(10), [e46191]. https://doi.org/10.1371/journal.pone.0046191

Detectable Changes in The Blood Transcriptome Are Present after Two Weeks of Antituberculosis Therapy. / Bloom, Chloe I.; Graham, Christine M.; Berry, Matthew P R; Wilkinson, Katalin A.; Oni, Tolu; Rozakeas, Fotini; Xu, Zhaohui; Rossello-Urgell, Jose; Chaussabel, Damien J.; Banchereau, Jacques; Pascual, Virginia; Lipman, Marc; Wilkinson, Robert J.; O'Garra, Anne.

In: PLoS One, Vol. 7, No. 10, e46191, 02.10.2012.

Research output: Contribution to journalArticle

Bloom, CI, Graham, CM, Berry, MPR, Wilkinson, KA, Oni, T, Rozakeas, F, Xu, Z, Rossello-Urgell, J, Chaussabel, DJ, Banchereau, J, Pascual, V, Lipman, M, Wilkinson, RJ & O'Garra, A 2012, 'Detectable Changes in The Blood Transcriptome Are Present after Two Weeks of Antituberculosis Therapy', PLoS One, vol. 7, no. 10, e46191. https://doi.org/10.1371/journal.pone.0046191
Bloom, Chloe I. ; Graham, Christine M. ; Berry, Matthew P R ; Wilkinson, Katalin A. ; Oni, Tolu ; Rozakeas, Fotini ; Xu, Zhaohui ; Rossello-Urgell, Jose ; Chaussabel, Damien J. ; Banchereau, Jacques ; Pascual, Virginia ; Lipman, Marc ; Wilkinson, Robert J. ; O'Garra, Anne. / Detectable Changes in The Blood Transcriptome Are Present after Two Weeks of Antituberculosis Therapy. In: PLoS One. 2012 ; Vol. 7, No. 10.
@article{c24cfe0350c645429345f170c68d4c67,
title = "Detectable Changes in The Blood Transcriptome Are Present after Two Weeks of Antituberculosis Therapy",
abstract = "Rationale: Globally there are approximately 9 million new active tuberculosis cases and 1.4 million deaths annually. Effective antituberculosis treatment monitoring is difficult as there are no existing biomarkers of poor adherence or inadequate treatment earlier than 2 months after treatment initiation. Inadequate treatment leads to worsening disease, disease transmission and drug resistance. Objectives: To determine if blood transcriptional signatures change in response to antituberculosis treatment and could act as early biomarkers of a successful response. Methods: Blood transcriptional profiles of untreated active tuberculosis patients in South Africa were analysed before, during (2 weeks and 2 months), at the end of (6 months) and after (12 months) antituberculosis treatment, and compared to individuals with latent tuberculosis. An active-tuberculosis transcriptional signature and a specific treatment-response transcriptional signature were derived. The specific treatment response transcriptional signature was tested in two independent cohorts. Two quantitative scoring algorithms were applied to measure the changes in the transcriptional response. The most significantly represented pathways were determined using Ingenuity Pathway Analysis. Results: An active tuberculosis 664-transcript signature and a treatment specific 320-transcript signature significantly diminished after 2 weeks of treatment in all cohorts, and continued to diminish until 6 months. The transcriptional response to treatment could be individually measured in each patient. Conclusions: Significant changes in the transcriptional signatures measured by blood tests were readily detectable just 2 weeks after treatment initiation. These findings suggest that blood transcriptional signatures could be used as early surrogate biomarkers of successful treatment response.",
author = "Bloom, {Chloe I.} and Graham, {Christine M.} and Berry, {Matthew P R} and Wilkinson, {Katalin A.} and Tolu Oni and Fotini Rozakeas and Zhaohui Xu and Jose Rossello-Urgell and Chaussabel, {Damien J.} and Jacques Banchereau and Virginia Pascual and Marc Lipman and Wilkinson, {Robert J.} and Anne O'Garra",
year = "2012",
month = "10",
day = "2",
doi = "10.1371/journal.pone.0046191",
language = "English",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - Detectable Changes in The Blood Transcriptome Are Present after Two Weeks of Antituberculosis Therapy

AU - Bloom, Chloe I.

AU - Graham, Christine M.

AU - Berry, Matthew P R

AU - Wilkinson, Katalin A.

AU - Oni, Tolu

AU - Rozakeas, Fotini

AU - Xu, Zhaohui

AU - Rossello-Urgell, Jose

AU - Chaussabel, Damien J.

AU - Banchereau, Jacques

AU - Pascual, Virginia

AU - Lipman, Marc

AU - Wilkinson, Robert J.

AU - O'Garra, Anne

PY - 2012/10/2

Y1 - 2012/10/2

N2 - Rationale: Globally there are approximately 9 million new active tuberculosis cases and 1.4 million deaths annually. Effective antituberculosis treatment monitoring is difficult as there are no existing biomarkers of poor adherence or inadequate treatment earlier than 2 months after treatment initiation. Inadequate treatment leads to worsening disease, disease transmission and drug resistance. Objectives: To determine if blood transcriptional signatures change in response to antituberculosis treatment and could act as early biomarkers of a successful response. Methods: Blood transcriptional profiles of untreated active tuberculosis patients in South Africa were analysed before, during (2 weeks and 2 months), at the end of (6 months) and after (12 months) antituberculosis treatment, and compared to individuals with latent tuberculosis. An active-tuberculosis transcriptional signature and a specific treatment-response transcriptional signature were derived. The specific treatment response transcriptional signature was tested in two independent cohorts. Two quantitative scoring algorithms were applied to measure the changes in the transcriptional response. The most significantly represented pathways were determined using Ingenuity Pathway Analysis. Results: An active tuberculosis 664-transcript signature and a treatment specific 320-transcript signature significantly diminished after 2 weeks of treatment in all cohorts, and continued to diminish until 6 months. The transcriptional response to treatment could be individually measured in each patient. Conclusions: Significant changes in the transcriptional signatures measured by blood tests were readily detectable just 2 weeks after treatment initiation. These findings suggest that blood transcriptional signatures could be used as early surrogate biomarkers of successful treatment response.

AB - Rationale: Globally there are approximately 9 million new active tuberculosis cases and 1.4 million deaths annually. Effective antituberculosis treatment monitoring is difficult as there are no existing biomarkers of poor adherence or inadequate treatment earlier than 2 months after treatment initiation. Inadequate treatment leads to worsening disease, disease transmission and drug resistance. Objectives: To determine if blood transcriptional signatures change in response to antituberculosis treatment and could act as early biomarkers of a successful response. Methods: Blood transcriptional profiles of untreated active tuberculosis patients in South Africa were analysed before, during (2 weeks and 2 months), at the end of (6 months) and after (12 months) antituberculosis treatment, and compared to individuals with latent tuberculosis. An active-tuberculosis transcriptional signature and a specific treatment-response transcriptional signature were derived. The specific treatment response transcriptional signature was tested in two independent cohorts. Two quantitative scoring algorithms were applied to measure the changes in the transcriptional response. The most significantly represented pathways were determined using Ingenuity Pathway Analysis. Results: An active tuberculosis 664-transcript signature and a treatment specific 320-transcript signature significantly diminished after 2 weeks of treatment in all cohorts, and continued to diminish until 6 months. The transcriptional response to treatment could be individually measured in each patient. Conclusions: Significant changes in the transcriptional signatures measured by blood tests were readily detectable just 2 weeks after treatment initiation. These findings suggest that blood transcriptional signatures could be used as early surrogate biomarkers of successful treatment response.

UR - http://www.scopus.com/inward/record.url?scp=84867031010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867031010&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0046191

DO - 10.1371/journal.pone.0046191

M3 - Article

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e46191

ER -